- Home
- BBGI vs APLM Comparison
BBGI vs APLM Comparison
Compare BBGI & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- APLM
- Stock Information
- Founded
- BBGI 1961
- APLM 2016
- Country
- BBGI United States
- APLM United States
- Employees
- BBGI N/A
- APLM N/A
- Industry
- BBGI Broadcasting
- APLM Blank Checks
- Sector
- BBGI Consumer Discretionary
- APLM Finance
- Exchange
- BBGI Nasdaq
- APLM Nasdaq
- Market Cap
- BBGI 13.2M
- APLM 12.3M
- IPO Year
- BBGI 2000
- APLM N/A
- Fundamental
- Price
- BBGI $8.27
- APLM $9.56
- Analyst Decision
- BBGI
- APLM Strong Buy
- Analyst Count
- BBGI 0
- APLM 2
- Target Price
- BBGI N/A
- APLM $425.00
- AVG Volume (30 Days)
- BBGI 7.9K
- APLM 36.2K
- Earning Date
- BBGI 02-10-2025
- APLM 02-15-2025
- Dividend Yield
- BBGI N/A
- APLM N/A
- EPS Growth
- BBGI N/A
- APLM N/A
- EPS
- BBGI 1.69
- APLM N/A
- Revenue
- BBGI $238,754,777.00
- APLM $2,101,000.00
- Revenue This Year
- BBGI $2.55
- APLM N/A
- Revenue Next Year
- BBGI N/A
- APLM N/A
- P/E Ratio
- BBGI $4.90
- APLM N/A
- Revenue Growth
- BBGI N/A
- APLM 70.54
- 52 Week Low
- BBGI $7.60
- APLM $6.50
- 52 Week High
- BBGI $18.80
- APLM $91.00
- Technical
- Relative Strength Index (RSI)
- BBGI 41.01
- APLM 46.48
- Support Level
- BBGI $8.20
- APLM $9.50
- Resistance Level
- BBGI $9.46
- APLM $10.67
- Average True Range (ATR)
- BBGI 0.43
- APLM 0.92
- MACD
- BBGI -0.06
- APLM -0.04
- Stochastic Oscillator
- BBGI 4.61
- APLM 13.17
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.